Xvivo Perfusion AB (publ) (XVIPF)
USD 33.45
(0.0%)
USD 33.45
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 69.36 Million SEK | 6.15% |
| 2022 | 65.08 Million SEK | 66.54% |
| 2021 | 39.19 Million SEK | 330.94% |
| 2020 | -26.86 Million SEK | -155.72% |
| 2019 | 30.43 Million SEK | -11.74% |
| 2018 | 20.24 Million SEK | 53.52% |
| 2017 | 22.47 Million SEK | 37.96% |
| 2016 | 16.31 Million SEK | -14.76% |
| 2015 | 19.13 Million SEK | 64.53% |
| 2014 | 11.72 Million SEK | -5.08% |
| 2013 | 12.25 Million SEK | 5680.19% |
| 2012 | 212 Thousand SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 43.64 Million SEK | 52.91% |
| 2024 Q3 | 20.47 Million SEK | -53.09% |
| 2024 Q1 | 18.99 Million SEK | 533.0% |
| 2023 FY | - SEK | 6.15% |
| 2023 Q2 | 3.8 Million SEK | -66.07% |
| 2023 Q4 | 4.5 Million SEK | -14.96% |
| 2023 Q3 | 5.3 Million SEK | 39.45% |
| 2023 Q1 | 11.2 Million SEK | -40.43% |
| 2022 FY | - SEK | 66.54% |
| 2022 Q3 | -4.65 Million SEK | -212.54% |
| 2022 Q2 | 4.13 Million SEK | -10.51% |
| 2022 Q4 | 18.81 Million SEK | 503.99% |
| 2022 Q1 | 4.62 Million SEK | -73.02% |
| 2021 Q1 | 3.18 Million SEK | 112.46% |
| 2021 Q3 | -4.03 Million SEK | 56.89% |
| 2021 FY | - SEK | 330.94% |
| 2021 Q4 | 17.13 Million SEK | 525.18% |
| 2021 Q2 | -9.35 Million SEK | -393.75% |
| 2020 Q2 | -8.21 Million SEK | -35800.0% |
| 2020 FY | - SEK | -155.72% |
| 2020 Q1 | 23 Thousand SEK | -99.29% |
| 2020 Q3 | -18.66 Million SEK | -127.28% |
| 2020 Q4 | -25.55 Million SEK | -36.93% |
| 2019 Q1 | -1.86 Million SEK | -119.12% |
| 2019 FY | - SEK | -11.74% |
| 2019 Q4 | 3.23 Million SEK | 41.9% |
| 2019 Q3 | 2.27 Million SEK | 18.04% |
| 2019 Q2 | 1.92 Million SEK | 203.6% |
| 2018 Q1 | 3.14 Million SEK | -39.36% |
| 2018 FY | - SEK | 53.52% |
| 2018 Q4 | 9.74 Million SEK | 1219.78% |
| 2018 Q3 | 738 Thousand SEK | -81.55% |
| 2018 Q2 | 3.99 Million SEK | 26.99% |
| 2017 Q1 | 13 Thousand SEK | -96.63% |
| 2017 FY | - SEK | 37.96% |
| 2017 Q4 | 5.19 Million SEK | 1234.96% |
| 2017 Q3 | 389 Thousand SEK | -80.2% |
| 2017 Q2 | 1.96 Million SEK | 15015.38% |
| 2016 Q1 | 1.77 Million SEK | -62.06% |
| 2016 FY | - SEK | -14.76% |
| 2016 Q4 | 386 Thousand SEK | 152.73% |
| 2016 Q3 | -732 Thousand SEK | -143.99% |
| 2016 Q2 | 1.66 Million SEK | -6.31% |
| 2015 Q1 | -15 Thousand SEK | -102.91% |
| 2015 FY | - SEK | 64.53% |
| 2015 Q4 | 4.68 Million SEK | 250.9% |
| 2015 Q3 | 1.33 Million SEK | -10.95% |
| 2015 Q2 | 1.49 Million SEK | 10086.67% |
| 2014 FY | - SEK | -5.08% |
| 2014 Q1 | 2.73 Million SEK | 2.01% |
| 2014 Q4 | 516 Thousand SEK | -77.2% |
| 2014 Q3 | 2.26 Million SEK | 63.04% |
| 2014 Q2 | 1.38 Million SEK | -49.31% |
| 2013 Q2 | 2 Million SEK | -42.14% |
| 2013 Q1 | 3.46 Million SEK | 333.29% |
| 2013 FY | - SEK | 5680.19% |
| 2013 Q4 | 2.68 Million SEK | -0.3% |
| 2013 Q3 | 2.69 Million SEK | 34.4% |
| 2012 FY | - SEK | 0.0% |
| 2012 Q4 | 799 Thousand SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Avitar, Inc. | -1.66 Million USD | 4259.304% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 6059.536% |
| Urologix, Inc. | -6.34 Million USD | 1193.458% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 13595.258% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 11125.25% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 137.38 Million USD | 49.506% |
| Össur hf. | 137.38 Million USD | 49.506% |
| SS Innovations International, Inc. | -20.37 Million USD | 440.445% |
| VMS Rehab Systems, Inc. | -68.55 USD | 101194848.359% |
| QHSLab, Inc. | -91.29 Thousand USD | 76085.015% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| BrainsWay Ltd. | -2.31 Million USD | 3101.688% |
| BioElectronics Corporation | -274.29 Thousand USD | 25390.386% |
| Hamilton Thorne Ltd. | 5.52 Million USD | -1156.315% |
| Theraclion SA | -2.05 Million USD | 3482.557% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -1.45 Million USD | 4876.983% |
| Stratec SE | 39.91 Million USD | -73.796% |
| AVITA Medical, Inc. | -39.56 Million USD | 275.317% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 58758.538% |
| Zecotek Photonics Inc. | -3.44 Million USD | 2115.241% |
| Wellstar International, Inc. | -1.35 Million USD | 5213.754% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | -609.723% |
| Escalon Medical Corp. | -58.46 Thousand USD | 118758.593% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 2319.098% |
| Aurora Spine Corporation | -454.37 Thousand USD | 15366.804% |
| NewCardio, Inc. | -9.37 Million USD | 839.595% |
| Vivos Inc. | -2.79 Million USD | 2583.544% |
| MicroPort Scientific Corporation | -347.57 Million USD | 119.958% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 35189.61% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 4257.432% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 18407.707% |
| Nanomix Corporation | -8.13 Million USD | 952.223% |
| IR-Med Inc. | -4.89 Million USD | 1518.009% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 9911.323% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 4128.666% |
| Lombard Medical, Inc. | -28.06 Million USD | 347.146% |
| ALR Technologies Inc. | -6.4 Million USD | 1183.837% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -68620.961% |
| Heart Tronics, Inc. | -14.85 Million USD | 566.915% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 622.481% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 857.966% |
| Ingen Technologies, Inc. | -8639.00 USD | 803074.881% |
| United American Healthcare Corporation | -59 Thousand USD | 117674.576% |
| Odyssey Group International, Inc. | -2.13 Million USD | 3344.462% |
| ECGI Holdings, Inc. | -2.99 Million USD | 2419.698% |
| Polarean Imaging plc | -11.19 Million USD | 719.643% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -15110.499% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 5697.159% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 9156.395% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 31232.584% |
| Smith & Nephew plc | 1 Billion USD | 93.081% |
| NIOX Group Plc | 11.07 Million USD | -526.351% |
| Fuse Medical, Inc. | 1.83 Million USD | -3679.676% |
| Broncus Holding Corporation | -25.19 Million USD | 375.287% |
| Brain Scientific Inc. | -7.93 Million USD | 974.356% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 838.683% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 377105.435% |